This article available in Chinese version only

恒指搖瞻ㄘw 兩手準備可留意牛67589/熊56076

2021-03-01 10:14:17

恒指29,000點失而復得,上周吸引大量恒指好倉流入博反彈,周五流入超過2.57億元,當中以牛證佔多數。恒指開盤反彈477點,短期阻力可留意20天線即29,800點水平,支持區則可以29,000點作參考。最新公布的內地2月份的官方製造業採購經理指數錄得50.6,按月跌0.7個百分點,但仍處於50的盛衰分界線之上,反映總體持續擴張。報導指本周將會是兩會會期,市場焦點落於經濟、先進科技產業自主等高質量發展之上。投資者如看好外圍投資氣氛將利好港股表現,高槓桿選擇可留意恒指牛證67589,收回價 28,700 點, 2023年7月到期 ,實際槓桿 52 倍。看淡可留意恒指熊證56076,收回價 29,719 點, 2021年11月到期 ,實際槓桿 40.2 倍。

個股方面,美團(3690)同期錄得超過4,300萬元流入好倉為個股第三多。美團股價上周失守350元即50天線,早段大幅反彈,暫於 360元之下徘徊。看好可留意美團牛證63708,收回價 334.88 元, 2021年10月到期 ,實際槓桿 14.8 倍。相反淡倉可留意美團熊證55899,收回價 400.88 元, 2021年11月到期 ,實際槓桿 6.3 倍。

 

其他滙豐輪證焦點:

恒指認購證19633,行使價 31148 點, 2021年7月到期 ,實際槓桿 10.1 倍。

恒指認沽證21809,行使價 27388 點, 2021年7月到期 ,實際槓桿 7.9 倍。

 

美團認購證22558,行使價 423.88 元, 2021年7月到期 ,實際槓桿 4.8 倍。

美團認沽證22540,行使價 283.88 元, 2021年7月到期 ,實際槓桿 4.3 倍。

 

更新日期及時間: 2021年3月1日  上午10:00

Intrady newsletters
Back to Intrady newsletters
本結構性產品並無抵押品,如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。

本文由香港上海匯豐銀行有限公司(「本行」或「發行商」)發行(包括任何參考條款),僅供參考之用,並不構成邀約、游說、或建議出售或購買結構性產品。

結構性產品屬複雜產品,投資者務須就此審慎行事,除非投資者完全了解及願意承擔所涉風險,否則切勿投資此產品。結構性產品價格可急升可急跌,投資者或會損失所有或大部分投資。過往表現並不反映將來表現。投資前應了解結構性產品之性質及風險,並詳閱有關上市文件,獨立決定是否適合自己,若需要應諮詢專業建議。本行及其委任之流通量提供者可能是結構性產品的唯一市場參與者,而結構性產品的二級市場可能有限。謹請注意,牛熊證設有強制收回機制,因此有可能提早終止,在此情況下(i)N類牛熊證投資者會損失於牛熊證的全部投資;而(ii)R類牛熊證之剩餘價值則可能為零。界內證在市場是全新的結構性產品,現時在香港交易所並無類似上市產品可作比較。界內證具備有別於標準的特徵,其條款及定價或較其他標準權證複雜,其最大潛在回報為固定及設有上限。界內證價格變動可能與其掛鈎資產的價格變動不成比例或呈相反方向。

作者為金管局及證監會持牌人士,並無就結構性產品或相關資產持有任何直接或間接權益。
Sign up to our newsletter

Stay abreast of the trends with the latest investment insight and market updates.

Latest article

(Available in Chinese only)
Back to Intrady newsletters

Important Risk Warning

The structured products are not collateralized. If the issuer is insolvent or defaults, investors may not recover part or all of the amount due.

Structured products are complex products. Investors should exercise caution in relation to them. The price of the structured products may fall in value as rapidly as it may rise and investors may sustain a total or substantial loss of their investment. Prospective investors should ensure that they understand the nature and risks and seek professional advice where applicable. Please also note that CBBCs have a mandatory call feature and may therefore be subject to early termination, upon which (i) investors in category N CBBCs will lose all of their investments in the CBBCs; and (ii) the residual value of category R CBBCs may be zero. Inline warrants have been newly introduced to the market and there are no similar products currently listed on the Stock Exchange of Hong Kong Limited for comparison. Inline warrants carry exotic features, and their terms and pricing may be more complicated than standard derivative warrants. Maximum potential payoff is fixed and capped. Price movement of the inline warrants may be disproportionate or opposite to the price movement of the underlying asset. Trading structured products with United States (US) underlying index may be exposed to additional risks, including (a) risks relating to difference in trading days and hours, (b) less public information about the index and such information may not be available in Chinese, (c) political and economic risks relating to the index regions (such as the US), (d) exchange rate risks, (e) possible delay in settlement, and (f) publication of index level when component shares are not trading. Click here for "Terms of Use".

Disclaimer

By viewing this website or using any information or functions of this website, you are deemed to acknowledge that you agree to the Privacy and Security, Terms of Use and Hyperlink Policy. Click here for "Disclaimer".

All data/charts are for reference purposes only.